Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

turing_logo

After Daraprim, Turing Pharma submits first in-house candidate to FDA

October 6, 2015 Manufacturing and Production, Research and Development turing

Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …
News
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015 Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
News
medcity_bojo

Why London is at the heart of life sciences

October 5, 2015 Research and Development NHS

by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …
Feature
keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015 Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
News

Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA

October 2, 2015 Manufacturing and Production, Research and Development woodley equipment

Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …
News
Press release
stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015 Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
Appointment
genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015 Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
News
sandoz_building

FDA accepts Sandoz submission for Amgen biosimilar

October 2, 2015 Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars

Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …
News
gene

Berg joins Genomics England project to sequence 100,000 genomes

October 2, 2015 Medical Communications, Research and Development Berg, Genomics england, artificial intelligence

Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …
News
lungs_shiz

Verona Pharma’s respiratory drug proves positive in study

October 1, 2015 Research and Development COPD, verona pharma

Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …
News
novartissunlight_copy

Novartis’s secukinumab meets Phase 3 goals

October 1, 2015 Research and Development Novartis, Secukinumab, arthritis

Novartis has announced that its secukinumab medication for treatment of psoriatic arthritis (PsA), met its primary endpoint in the pivotal …
News
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …
News
novartis

Study shows Novartis’s Afinitor positively reduces tumors

September 30, 2015 Research and Development Afinitor, Novartis

Novartis has announced the results of a Phase III pivotal study, showing Afinitor (everolimus) tablets reduced the risk of progression …
News

Genentech’s ocrelizumab shows efficacy in phase III trial

September 30, 2015 Research and Development Genentech, MS, Roche, ocrelizumab

Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …
News
heptares_logo

Heptares awarded $5.5 million grant to combat cocaine addiction

September 30, 2015 Research and Development Heptares

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025